SPAG5 and cervical carcinoma: Searching further for the related mechanisms, a recent study indicated that SPAG5 regulated the sensitivity to taxol (aka., paclitaxel), a standard chemotherapy for TNBC, in cervical cancer cells (HeLa and SiHa) through altering mTOR activity [5].